Association for Accessible Medicines
USTRNonrulemakingUSTR-2018-0035

Negotiating Objectives for a U.S.-European Union Trade Agreement

RIN
Last modified
Feb 22, 2019
Comment window
closed 2782d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Dec 10, 2018 and Dec 10, 2018. 87 other organizations filed here. The comment window closed 2782d ago.

What Association for Accessible Medicines filed (1)

Dec 10, 2018· Association For Accessible Medicines (AAM)· USTR-2018-0035-0037

In response to the above-referenced notice, the Association for Affordable Medicine (AAM) hereby submits its request to testify as well as attached written comments in preparation for the negotiation of a U.S.-European Union (EU) Trade Agreement. AAM requests the opportunity to provide testimony at the December 14, 2018, hearing. The witness will be: Jeffrey K. Francer Senior Vice President & General Counsel Association for Accessible Medicines 601 New Jersey Ave. NW, Suite 850 Washington, DC 20001 Tel: 202-249-7128

Abstract

No abstract recorded.

View on regulations.gov →